Physician profile
David Aaron Tyson
NPI 1194305300
$808.49
in general payments reported to CMS, 2019-2025
9 companies · $203 in 2025
The $203 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $294 · 2024: $312 · 2025: $203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $800 · Education: $8.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $800.14 |
| Education | $8.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $299.26 | 2023-2025 | |
| Acadia Pharmaceuticals INC | $257.74 | 2023 | Nuplazid |
| Axsome Therapeutics, INC. | $125.00 | 2024 | Sunosi |
| Lundbeck LLC | $37.33 | 2025 | Rexulti |
| Otsuka America Pharmaceutical, INC. | $21.62 | 2025 | Rexulti |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $17.31 | 2025 | Caplyta |
| Corium, LLC | $17.10 | 2025 | Azstarys |
| Takeda Pharmaceuticals U.S.A., INC. | $16.69 | 2025 | Trintellix |
| Abbvie INC. | $16.44 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Tyson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.